Recent News

• 09.05.2025 - 2025 Wells Fargo Healthcare Conference
• 09.05.2025 - 2025 Wells Fargo Healthcare Conference
• 08.28.2025 - Kezar Life Sciences to Participate in Two Upcoming Investor Conferences
• 08.28.2025 - Kezar Life Sciences to Participate in Two Upcoming Investor Conferences
• 08.13.2025 - Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.13.2025 - Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update
• 07.15.2025 - Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis
• 07.15.2025 - Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis

Recent Filings

• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - 8-K Current report
• 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.23.2025 - 8-K Current report
• 06.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.23.2025 - 4 Statement of changes in beneficial ownership of securities